We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.07% | 1,334.00 | 1,333.00 | 1,334.00 | 1,337.50 | 1,333.00 | 1,335.00 | 227,312 | 08:26:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.23 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
22/2/2023 10:41 | is this really a tory government?????????? no!! | lippy4 | |
22/2/2023 10:31 | Doesn't sound like a Tory budget! | tradermichael | |
22/2/2023 10:25 | Yes is 2024 he talking about reducing divi allowance to £500... if not in an isa you would have to tax return and declare anything over that..You will hear it all in the chancellor budget next month | mj19 | |
22/2/2023 10:18 | £1000 limit for dividends really ? A friend of.mine makes £20k from GSK worked.there all his life never sold a share over £2milliom total | alibizzle | |
22/2/2023 09:41 | If he is very young he might not have built up a big enough ISA pot. It only works after about 10 years worth of deposits. | netcurtains | |
22/2/2023 09:39 | mj19 use isa's, no tax on capital gains either.. | tradermichael | |
22/2/2023 09:26 | I hope so...Annoyed if the April budget drops the dividends per year to £1000 limit and cgt to 6k instead of 12k no way to make good money... GSK divi gives me over 1k ...on its own!! | mj19 | |
22/2/2023 08:53 | MJ19:Not 'always' for long. There have been times where the initial drop recovers through the day .... depends on the general market and on GSK sentiment | tradermichael | |
22/2/2023 08:38 | MJ19: I dont see why.. I thought you can buy today to get the dividend. That means you can get the bounce back and the dividend. It doesn't go ex-dividend until tomorrow. | netcurtains | |
22/2/2023 08:37 | Always falls more than the ex divi amount tomorrow annoying | mj19 | |
21/2/2023 15:53 | The US ADRs are pushing ahead of UK prices.... | netcurtains | |
21/2/2023 15:26 | Crazy that AZNs mcap is currently 3 times GSKs. Seems to me the former is overbought and latter is oversold but it's clear they will need some important pipeline progress for this to re-rate whilst also needing to legally discount the whole Zantac litigation question | rikky72 | |
21/2/2023 15:26 | net - xdiv is 23rd, so if you buy tomorrow you qualify for the div. | tradermichael | |
21/2/2023 15:25 | £17 to and I break even and leave | alibizzle | |
21/2/2023 15:24 | I've no idea | alibizzle | |
21/2/2023 13:59 | zho: Oh thats good then! We can get to 1800 - but I guess it might be a long haul. | netcurtains | |
21/2/2023 13:47 | >>I dont see how it can go to 1800 as they gave us loads of free HLN.>> Rump GSK had a 5 for 4 consolidation when HLN was spun off, leaving the share price pretty much where it was before. | zho | |
21/2/2023 13:42 | I dont see how it can go to 1800 as they gave us loads of free HLN. Surely that has to be part of the price... So 1650 to 1700 seems more possible.... | netcurtains | |
21/2/2023 13:40 | Is this going back to 1800? | brucie5 | |
21/2/2023 12:49 | Alibizzle: does that mean 26th is last time to buy or first day to sell after dividend? Thanks | netcurtains | |
21/2/2023 10:51 | Phew thats OK then. I'm getting all the dates confused. Thanks for clarifying. | netcurtains | |
21/2/2023 10:37 | I thought court case was Feb 27 | alibizzle | |
21/2/2023 09:58 | LOL - two big events on one day. Or will the court case not be a big thing - too early to have any meaning? | netcurtains | |
21/2/2023 09:55 | Ex div is THURSDAY | tradermichael |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions